Rachel Sanford

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study”.

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

The Lancet(2023)10.1016/s0140-6736(23)01857-3

N/A

4.7DataRank · unranked

264 citations

Jonathan T. Yang, Juber Patel, Annemarie F. Shepherd, Juliana Eng, Randy Yeh +44 more

Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0855

N/A

2.2DataRank · unranked

68 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578.v1

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Quality of Life in Patients with Malignant Wounds Treated at a Wound Care Clinic

Research Square(2024)10.21203/rs.3.rs-4797536/v1

N/A

0DataRank · unranked

2 citations

Stephen W. Dusza, Jacqueline Bromberg, Shari Goldfarb, Rachel Sanford, Alina Markova +1 more

Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy

JACC CardioOncology(2025)10.1016/j.jaccao.2025.05.006

N/A

0DataRank · unranked

8 citations

Chau T. Dang, Chaya S. Moskowitz, Akriti Mishra Meza, Patricia DeFusco, Eric Oligino +11 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: a feasibility study

Breast Cancer Research and Treatment(2022)10.1007/s10549-022-06669-2

N/A

0DataRank · unranked

17 citations

Ayca Gucalp, Sujata Patil, Marcia Edelweiss, Dara S. Ross, Pedram Razavi +17 more